Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEZAFIBRATE: 305 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
305
Total FAERS Reports
11 (3.6%)
Deaths Reported
132
Hospitalizations
305
As Primary/Secondary Suspect
29
Life-Threatening
18
Disabilities

First Report: 1999 · Latest Report: 20250420

What Are the Most Common BEZAFIBRATE Side Effects?

#1 Most Reported
Myalgia
29 reports (9.5%)
#2 Most Reported
Abdominal pain
25 reports (8.2%)
#3 Most Reported
Rhabdomyolysis
21 reports (6.9%)

All BEZAFIBRATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myalgia 29 9.5% 0 6
Abdominal pain 25 8.2% 0 10
Rhabdomyolysis 21 6.9% 0 17
Back pain 20 6.6% 0 4
Blood creatine phosphokinase increased 19 6.2% 0 5
Acute myocardial infarction 17 5.6% 0 3
Pancreatitis acute 17 5.6% 0 17
Pyrexia 16 5.3% 0 2
Acute coronary syndrome 15 4.9% 0 1
Drug intolerance 15 4.9% 0 0
Hypertension 15 4.9% 0 1
Off label use 15 4.9% 1 2
Pulmonary embolism 15 4.9% 1 15
Arthralgia 14 4.6% 1 2
Carotid arteriosclerosis 14 4.6% 0 0
Coronary artery occlusion 14 4.6% 0 1
Coronary artery thrombosis 14 4.6% 0 0
Diarrhoea 14 4.6% 0 10
Diverticular perforation 14 4.6% 0 0
Dyspnoea 14 4.6% 0 0

Who Reports BEZAFIBRATE Side Effects? Age & Gender Data

Gender: 41.5% female, 58.5% male. Average age: 61.3 years. Most reports from: JP. View detailed demographics →

Is BEZAFIBRATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2001 1 0 0
2007 1 0 0
2009 1 0 1
2010 12 0 4
2011 21 0 7
2013 7 0 4
2014 7 0 4
2015 7 1 5
2016 13 2 10
2017 11 0 9
2018 15 1 5
2019 28 1 12
2020 21 1 14
2021 18 0 14
2022 8 0 1
2023 4 0 3
2024 13 0 8
2025 1 0 1

View full timeline →

What Is BEZAFIBRATE Used For?

IndicationReports
Product used for unknown indication 97
Dyslipidaemia 44
Hyperlipidaemia 35
Hypercholesterolaemia 26
Blood cholesterol increased 13
Primary biliary cholangitis 13
Blood cholesterol 7
Cholangitis 6
Cholangitis sclerosing 6
Type iia hyperlipidaemia 6

BEZAFIBRATE vs Alternatives: Which Is Safer?

BEZAFIBRATE vs BEZLOTOXUMAB BEZAFIBRATE vs BGB-11417 BEZAFIBRATE vs BICALUTAMIDE BEZAFIBRATE vs BICTEGRAVIR BEZAFIBRATE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BEZAFIBRATE vs BIFIDOBACTERIUM LONGUM BEZAFIBRATE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BEZAFIBRATE vs BILASTINE BEZAFIBRATE vs BIMATOPROST BEZAFIBRATE vs BIMATOPROST\TIMOLOL

Official FDA Label for BEZAFIBRATE

Official prescribing information from the FDA-approved drug label.